Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04822259
Other study ID # Journey II CR + BCS.2020.12
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date August 28, 2022
Est. completion date December 31, 2025

Study information

Verified date June 2022
Source Smith & Nephew, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM) The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium (OXINIUM) Purpose: Post-market evidence generation for JOURNEY II BCS and JOURNEY II CR Total Knee System Objectives: 1. Evaluate the performance of JOURNEY II TKA in Asia-Pacific (APAC) patient populations 2. Establish the equivalent performance between JOURNEY II BCS and JOURNEY II CR to support adoption of JOURNEY II CR Research participants / locations: A total of at least 176 knees' information will be collected in up to 10 sites. There will be at least eighty-eight (88) knees for JOURNEY II CR TKA group and at least 88 knees for JOURNEY II BCS TKA group.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 31, 2025
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Subjects with degenerative osteoarthritis. - Subject is planning to have bilateral Total Knee Arthroplasty (TKA) using JOURNEY II BCS & CR or have unilateral TKA using JOURNEY II BCS or JOURNEY II CR.* - Subject is able and willing to provide voluntary consent to study participation. - Subject is 18-80 years old (inclusive). [* Bilateral cases can be simultaneous bilateral or staged bilateral (which an interval of 6-8 weeks apart between both knees)] Exclusion Criteria: - Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis. - Previous surgeries including High Tibial Osteotomy (HTO), Unicondylar Knee Arthroplasty (UKA) or Total Knee Arthroplasty (TKA) on the subject knee. - Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up. - Subject does not meet the indication or is contraindicated for JOURNEY II BCS & JOURNEY II CR's Instructions For Use (IFU).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
JOURNEY II BCS Total Knee System
Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System
JOURNEY II CR Total Knee System
Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System

Locations

Country Name City State
China Peking University Third Hospital Beijing
China Prince of Wales Hospital Hong Kong
India Aster RV Hospital, Bangalore Bengaluru Karnataka
India Noble Hospital & Ruby Hall Clinic Pune Maharashtra
Singapore Singapore General Hospital Singapore

Sponsors (1)

Lead Sponsor Collaborator
Smith & Nephew, Inc.

Countries where clinical trial is conducted

China,  India,  Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxford Knee Score (OKS) at 2 years The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome. 2 years
Secondary Forgotten Joint Score (FJS) The FJS comprises measures for the assessment of joint-specific patient reported outcomes. This questionnaire focuses on the study subject's awareness of the partially or fully replaced knee joint in everyday life. Joint awareness can be simply defined as any unintended perception of a joint. Subjects are asked to rate their awareness of their knee arthroplasty in 12 questions with a five-point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living. 6 months, 1 year , 2 years, 3 years
Secondary Oxford Knee Score (OKS) The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome. Pre-Operative, 6 months, 1 year, 3 years
Secondary Knee Society Score (KSS) The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales:
An "Objective" Knee Score (seven items: 100 points)
A Patient Satisfaction Score (five items: 40 points)
A Patient Expectation Score (three items: 15 points)
A Functional Knee Score (19 items: 100 points)
The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities. A higher number is a better outcome.
Pre-Operative, 6 months, 1 year, 2 years, 3 years
Secondary Patient Expectation The patient expectation will be one single question which have 9 options to choose.
Patients need to choose at which level of activity he/she expect to recover after surgery.
The option will be from the most intensive activity to least intensive activity.
Pre-Operative
Secondary Patient Satisfaction The patient satisfaction will be a corresponding question based on the expectation. It's a five -Likert options (from very satisfied to very dissatisfied) for patients to choose how satisfied he/she is with the surgery to meet the expectation. 6 months, 1 year, 2 years, 3 years
Secondary Radiographic Assessment Standard radiographic evaluation on antero-posterior (A/P) and lateral views shall be performed at the determined time point before and after surgery in order to identify any radiographic observations such as radiolucent lines around the implant components. The presence of radiolucent lines, osteolysis & implant migration shall be recorded in the electronic Case Report Form (eCRF). Pre-Operative, 6 months, 1 year, 2 years, 3 years
Secondary Timed Up and Go Test (TUG) The Timed Up and Go Test assesses mobility, balance, walking ability, and fall risk in adults by measuring time, in seconds, that it takes the individual to stand from a chair, walk a distance of 10 feet (around 3 meters), walk back to the chair, and sit down. The subject will perform the test in their everyday footwear with their walking aid (cane, walker), if applicable [39]. The site will follow the guidelines provided by the Centers for Disease Control and Prevention recording the results on the form provided by the Sponsor Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year
Secondary Star Excursion Balance Test (SEBT) The SEBT has been introduced as a simple, reliable, and cost-effective alternative for instrumental devices to assess semi-dynamic balance. The SEBT is a functional test that incorporates a single-leg stance on 1 leg while trying to reach as far as possible with the opposite leg. Each patient performed 3 reaches (trials) in each of the 8 directions. The average of the maximum reach distance in each of the 8 directions was considered for analysis. Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06323980 - INHANCE Stemless Reverse Shoulder IDE N/A
Completed NCT00762944 - Total Temporomandibular Joint Replacement System Post Approval Study
Not yet recruiting NCT05015101 - Evaluation of the Clinical and Radiological Outcome of Uncemented Femoral Stems According to Their Proximal Coating
Terminated NCT02713906 - Materialise X-ray Knee Guides for Total Knee Arthroplasty N/A
Completed NCT02554149 - Radiological Measurement of Femoral Stem Version Using Lateral Decubitus Method: A Prospective Study N/A
Recruiting NCT02828293 - Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy
Completed NCT02829866 - AMIStem-H Radiographic Analysis
Terminated NCT00683267 - Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement Phase 2
Completed NCT04516239 - Comparison of Metal on Metal Total Hip Arthroplasty and Metal on Metal Total Hip Resurfacing. Phase 4
Recruiting NCT04480320 - Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty N/A
Not yet recruiting NCT04906681 - Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study Phase 1/Phase 2
Completed NCT04403919 - Knotless Suture in Revision Total Joint Arthroplasty N/A
Completed NCT03132831 - Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements
Active, not recruiting NCT03339557 - Comparison of Three Knee Replacements N/A
Active, not recruiting NCT02578446 - Uncemented Tritanium Compared With Cemented Metal-backed Tibia Components in Total Knee Replacement N/A
Not yet recruiting NCT00756483 - Stability Plus - Outcomes From Extended Continuum of Care N/A
Terminated NCT00364533 - A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety Phase 3
Terminated NCT04089371 - A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System
Completed NCT05248854 - Effects of Sensorimotor and Core Stabilization Exercises After Total Knee Arthroplasty N/A
Not yet recruiting NCT02465684 - Effect of Tourniquet on UKA N/A